Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 256 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2412 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NOVAMOXIN | 250MG | CAPSULE | Resolved | 2020-04-02 | 2020-08-14 | 110667 |
| TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2020-04-03 | 2020-05-08 | 110749 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-04-10 | 2020-04-23 | 111841 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2020-04-10 | 2023-10-03 | 111874 |
| ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2020-05-08 | 2020-05-21 | 114436 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-05-14 | 2020-06-04 | 115196 |
| TEVA-AMPICILLIN | 250MG | CAPSULE | Resolved | 2020-05-14 | 2020-09-03 | 115210 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-07-10 | 2021-01-14 | 119956 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2020-07-23 | 2020-09-24 | 120905 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2020-09-17 | 2020-11-12 | 124477 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2020-09-25 | 2020-11-07 | 125028 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2020-11-06 | 2021-02-05 | 128013 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2021-05-20 | 2021-07-15 | 139734 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2021-08-05 | 2021-09-09 | 143734 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2021-09-30 | 2021-10-21 | 146434 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146466 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2021-10-07 | 2021-12-08 | 146850 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 250MG | POWDER FOR SOLUTION | Resolved | 2021-10-28 | 2021-11-25 | 148421 |
| TEVA-CLOXACILLIN | 250MG | CAPSULE | Resolved | 2021-10-28 | 2021-12-02 | 148424 |
| ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2021-11-25 | 2023-10-05 | 149931 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 |